Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?-Reference-Cited by-同舟云学术

Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?

Published:2018-03 Issue:2 Volume:44 Page:143-149
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Croyal M.,Kaabia Z.,León L.,Ramin-Mangata S.,Baty T.,Fall F.,Billon-Crossouard S.,Aguesse A.,Hollstein T.,Sullivan D.R.,Nobecourt E.,Lambert G.,Krempf M.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference39 articles.

1. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study;Kannel;Am Heart J,1985

2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial;Stamler;Diabetes Care,1993

3. Use of fibrates in the metabolic syndrome: a review;Shipman;World J Diabetes,2016

4. Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing;Farnier;Vasc Health Risk Manag,2008

5. Peroxisome proliferator activated receptors and lipoprotein metabolism;Kersten;PPAR Res,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extraction, purification, structural characterization and anti-hyperlipidemia activity of fucoidan from Laminaria digitata;International Journal of Biological Macromolecules;2024-11

2. Diurnal regulation of Acyl-CoA synthetase 3 (ACSF3) underlies daily mitochondrial lysine-malonylation and hepatic metabolism;2024-09-06

3. Sphingolipid and Trimethylamine-N-Oxide (TMAO) Levels in Women with Obesity after Combined Physical Training;Metabolites;2024-07-23

4. Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes;Diabetes & Metabolism;2024-07

5. PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets;Journal of Advanced Research;2024-03